Reversible infantile mitochondrial diseases

Journal of Inherited Metabolic Disease

Volumn 38, Issue 3, 2015, Pages 427-435

  Boczonadi, Veronika ^a   Bansagi, Boglarka ^a   Horvath, Rita ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5-METHYLAMINOMETHYL-2-THIOURIDYLATE; NUCLEOTIDE; PYRIMIDINE NUCLEOTIDE; TRANSFER RNA;

DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE EXPRESSION; GENETICS; HUMAN; INFANT; LIVER FAILURE; MITOCHONDRIAL MYOPATHY; MUTATION; NEWBORN;

GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; LIVER FAILURE; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MYOPATHIES; MUTATION; RNA, TRANSFER; THIONUCLEOTIDES; URACIL NUCLEOTIDES;

EID: 84939974387     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9784-6     Document Type: Article

References (39)

1. Baruffini E, Dallabona C, Invernizzi F et al (2013) MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum Mutat 34:1501–1509
2. Boczonadi V, Smith PM, Pyle A et al (2013) Altered 2-thiouridylation impairs mitochondrial translation in reversible infantile respiratory chain deficiency. Hum Mol Genet 22:4602–4615
3. Chrzanowska-Lightowlers ZM, Horvath R, Lightowlers RN (2010) 175th ENMC International Workshop: mitochondrial protein synthesis in health and disease, 25-27th June 2010, Naarden, The Netherlands. Neuromuscul Disord 21:142–147
4. DiMauro S, Nicholson JF, Hays AP, Eastwood AB, Koenigsberger R, DeVivo DC (1981) Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Trans Am Neurol Assoc 106:205–207
5. DiMauro S, Nicholson JF, Hays AP, Eastwood AB, Papadimitriou A, Koenigsberger R, DeVivo DC (1983) Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol 14:226–234
6. Gaignard P, Gonzales E, Ackermann O et al (2013) Mitochondrial infantile liver disease due to TRMU gene mutations: three New cases. JIMD Rep 11:117–123
7. Ghezzi D, Baruffini E, Haack TB et al (2012) Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am J Hum Genet 90:1079–1087
8. Guan MX, Yan Q, Li X et al (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 79:291–302
9. Horvath R, Kemp JP, Tuppen HA et al (2009) Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 132:3165–3174
10. Kemp JP, Smith PM, Pyle A et al (2011) Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain 134:183–195
11. Lax NZ, Gnanapavan S, Dowson SJ et al (2013) Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study. J Neuropathol Exp Neurol 72:164–175
12. Levinger L, Mörl M, Florentz C (2004) Mitochondrial tRNA 3′ end metabolism and human disease. Nucleic Acids Res 32:5430–5441
13. Levonen AL, Lapatto R, Saksela M, Raivio KO (2000) Human cystathionine gamma-lyase: developmental and in vitro expression of two isoforms. Biochem J 347:291–295
14. Macmillan CJ, Shoubridge EA (1996) Mitochondrial DNA depletion: prevalence in a pediatric population referred for neurologic evaluation. Pediatr Neurol 14:203–210
15. Mancuso M, Orsucci D, Logerfo A et al (2010) Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol 257:774–781
16. Mimaki M, Hatakeyama H, Komaki H et al (2010) Reversible infantile respiratory chain deficiency: a clinical and molecular study. Ann Neurol 68:845–854
17. Morten KJ, Ashley N, Wijburg F et al (2007) Liver mtDNA content increases during development: a comparison of methods and the importance of age- and tissue-specific controls for the diagnosis of mtDNA depletion. Mitochondrion 7:386–395
18. Nonaka I, Koga Y, Shikura K et al (1988) Muscle pathology in cytochrome c oxidase deficiency. Acta Neuropathol 77:152–160
19. Roodhooft AM, Van Acker KJ, Martin JJ, Ceuterick C, Scholte HR, Luyt-Houwen IE (1986) Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase. Neuropediatrics 17:221–226
20. Rorbach J, Yusoff AA, Tuppen H et al (2008) Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation. Nucleic Acids Res 36:3065–3074
21. Rötig A (2011) Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta 1807:1198–1205
22. Russell O, Turnbull D (2014) Mitochondrial DNA disease-molecular insights and potential routes to a cure. Exp Cell Res 325:38–43
23. Salmi H, Leonard JV, Rahman S, Lapatto R (2012) Plasma thiol status is altered in children with mitochondrial diseases. Scand J Clin Lab Invest 72:152–157
24. Salo MK, Rapola J, Somer H, Pihko H, Koivikko M, Tritschler HJ, DiMauro S (1992) Reversible mitochondrial myopathy with cytochrome c oxidase deficiency. Arch Dis Child 67:1033–1035
25. Sasarman F, Antonicka H, Horvath R, Shoubridge EA (2011) The 2-thiouridylase function of the human MTU1 (TRMU) enzyme is dispensable for mitochondrial translation. Hum Mol Genet 20:4634–4643
26. Schara U, von Kleist-Retzow JC, Lainka E et al (2011) Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J Inherit Metab Dis 34:197–201
27. Smits P, Smeitink J, van den Heuvel L (2010) Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010:737385
28. Steenweg ME, Ghezzi D, Haack T et al (2012) Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’ caused by EARS2 mutations. Brain 135:1387–1394
29. Sturman JA, Gaull G, Raiha NC (1970) Absence of cystathionase in human fetal liver: is cystine essential? Science 169:74–76
30. Taanman JW, Hall RE, Tang C, Marusich MF, Kennaway NG, Capaldi RA (1993) Tissue distribution of cytochrome c oxidase isoforms in mammals. Characterization with monoclonal and polyclonal antibodies. Biochim Biophys Acta 1225:95–100
31. Talim B, Pyle A, Griffin H et al (2013) Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation. Brain 136:e228
32. Taylor RW, Pyle A, Griffin H, et al (2014) Whole exome sequencing defines the genetic basis of multiple mitochondrial respiratory chain complex deficiency. JAMA in press June 2014
33. Tritschler HJ, Bonilla E, Lombes A et al (1991) Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology 41:300–305
34. Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 1797:113–128
35. Uusimaa J, Jungbluth H, Fratter C et al (2011) Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease. J Med Genet 48:660–668
36. Viscomi C, Burlina AB, Dweikat I et al (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16:869–871
37. Wada H, Woo M, Nishio H et al (1996) Vascular involvement in benign infantile mitochondrial myopathy caused by reversible cytochrome c oxidase deficiency. Brain Dev 18:263–268
38. Zeharia A, Shaag A, Pappo O et al (2009) Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 85:401–407
39. Zeviani M, Peterson P, Servidei S, Bonilla E, DiMauro S (1987) Benign reversible muscle cytochrome c oxidase deficiency: a second case. Neurology 37:64–67